Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.
Scientific Data volume 10, Article number: 914 (2023 ) Cite this article Sleep Specialist
Self-emulsifying drug delivery systems (SEDDS) are a well-established formulation strategy for improving the oral bioavailability of poorly water-soluble drugs. Traditional development of these formulations relies heavily on empirical observation to assess drug and excipient compatibility, as well as to select and optimize the formulation compositions. The aim of this work was to leverage previously developed SEDDS in the literature to construct a comprehensive SEDDS dataset that can be used to gain insights and advance data-driven approaches to formulation development. A dataset comprised of 668 unique SEDDS formulations encompassing 20 poorly water-soluble drugs was curated. While there are still opportunities to enhance the quality and quantity of data on SEDDS, this research lays the groundwork to potentially simplify the SEDDS formulation development process.
Lena Dalal, Abdul Wahab Allaf & Hind El-Zein
Pauric Bannigan, Zeqing Bao, … Christine Allen
Sumit Mukesh, Goutam Mukherjee, … Rebecca C. Wade
Poor aqueous solubility and permeability are recognized as major contributors to limited oral drug bioavailability. Indeed, these are integral considerations of theoretical frameworks such as Lipinski’s Rule of Five, the Biopharmaceutical Classification System (BCS), and the expanded Developability Classification System (DCS), which provide ways to differentiate promising drugs for oral administration1,2,3. Over time, it has been reported that a growing number of small molecule drug candidates exhibit properties that may hinder oral absorption. In fact, in the 20 years since the rule of five was first proposed, new chemical entities approved by the FDA have been shown to increase in molecular weight and calculated water-octanol partition coefficient (clogP)4,5. In general, the successful clinical approval of less traditionally drug-like molecules underscores the critical role of pharmaceutical formulations.
Advanced lipid-based formulation strategies have enabled enhancement of oral absorption of drugs with poor water solubility and/or low intestinal permeability (i.e., BCS II and IV drugs). One such example is self-emulsifying drug delivery systems (SEDDS), a combination of oils, surfactants, and/or cosolvents that spontaneously emulsify in the aqueous environment of the gastrointestinal tract6. The ability of SEDDS formulations to improve oral bioavailability has been attributed to a number of mechanisms, notably through increased apparent solubility of highly lipophilic drugs, as well as reduced metabolism or efflux7. As a result, several clinically approved drugs rely on delivery in SEDDS formulations including cyclosporine A (e.g., Sandimmune, Neoral), tipranavir (e.g., Aptivus), and fenofibrate (e.g., Lipofen), among others8,9,10.
Despite the relative simplicity of SEDDS in principle, the path to design such formulations remains non-trivial. The traditional approach to SEDDS development is an empirical process relying on iterative trial-and-error to screen, optimize, and evaluate the formulations. One of the most pertinent questions lies with the selection of appropriate excipients and mixtures thereof. Typically, this begins with quantification of the drug solubility in excipients, followed by screening excipient mixtures based on their emulsification properties, through visual assessment11. Given the range of possible excipients for SEDDS (i.e., oils, surfactants, cosolvents – all of which may differ in terms of hydrophilicity/lipophilicity, purity, etc.), selection is often narrowed based on generally recognized as safe (GRAS) status. An established tool to facilitate the process of formulation development is the Lipid-based Formulation Classification System (LFCS). The LFCS defines four categories of oral lipid-based formulations according to their compositions, which essentially range from a pure mixture of oils to a combination of exclusively surfactants and cosolvents6. While the LFCS relates these compositional ranges to typical properties, it does not eliminate the need to develop bespoke formulations by exploring various excipient combinations. Nonetheless, methods to shift away from the traditional development of SEDDS have emerged, largely employing data-driven tools.
In recent years, there has been significant interest in the integration of artificial intelligence (AI) and machine learning (ML) in pharmaceutical sciences, including drug formulation. These tools have been used in a variety of advanced applications, from the expedited design of polymeric long-acting injectables to engineering peptides for sustained delivery to the eye, and the development of ionizable lipids for lipid nanoparticle delivery of mRNA12,13,14. In the context of oral lipid-based formulations, ML and computational techniques have played a role in early-stage development, notably based on small molecule drug solubility screening15. Preliminary ML modeling has been used to predict drug supersaturation in lipid-based formulations and increases in the apparent solubility of drug upon dispersion of SEDDS16,17. In these cases, a limited number of formulation compositions (i.e., two representative examples) were explored. Few studies have performed extensive investigations relating to SEDDS compositions. One example includes an approach integrating ML and molecular dynamics to predict self-emulsification regions for SEDDS formulations, which also reported the distribution of excipients in their dataset18. However, this study did not identify drugs that were in the formulations in the dataset.
Thus, although SEDDS are a well-established formulation strategy, there are currently no open-access SEDDS datasets with a focus on formulation composition. Here, we present a literature mined SEDDS dataset containing 668 unique formulations, with drug, excipient, and formulation features that may be used to better understand composition patterns or relationships and predict formulation properties (Fig. 1). Our dataset contributes to the development of SEDDS formulations by providing a resource with documented formulations and related information that may serve as a starting point for excipient selection and screening.
A schematic overview of the study. Graphical illustration of self-emulsifying drug delivery systems (SEDDS), which spontaneously emulsify into colloidal particles upon dispersion of the preconcentrate (i.e., drug-excipient mixture) in aqueous media (a). Workflow for the collection of the SEDDS dataset (b).
All SEDDS formulations in the dataset were collected from published literature. The dataset was constructed based on a search of the Web of Science database covering its inception to March 2023, using the keywords “self-emulsifying drug delivery systems” or “SEDDS” or “SNEDDS” or “SMEDDS” and “drug” from a list of 20 poorly water-soluble drugs (i.e., active pharmaceutical ingredients (APIs)). Search results were limited to articles and filtered by publisher (i.e., Elsevier, Springer Nature, Taylor & Francis, Wiley, MDPI). An initial pool of 307 articles were manually screened, yielding 152 articles that encompassed 668 unique formulations for inclusion in the dataset (Fig. 2). Articles were omitted if they did not provide relevant information, such as insufficient formulation compositional details, description of formulations not corresponding to the drug in question, or a non-unique formulation. The full list of source studies is provided in the source and DOI columns of the sedds_dataset_full.csv file.
Sankey diagram illustrating the number of articles identified and screened for construction of the SEDDS dataset. An initial pool of 307 articles was selected following a search of the Web of Science database. Manual screening of the articles yielded 152 articles containing 668 unique formulations for inclusion in the dataset. Meandering flows indicate article searches that corresponded to one drug but provided relevant information for a different drug.
Information obtained for an individual sample in the dataset included the identity and relative proportion of the drug, as well as each individual excipient (i.e., oils, surfactants, cosolvents, and other ingredients). Other additives or ingredients were grouped by function (e.g., absorption enhancer, precipitation inhibitor, etc.), as opposed to the individual identity, to facilitate downstream analysis. The proportions of each component for a given formulation were standardized as compositional data, such that they totaled to 100% in units by weight. Additional descriptors included the average particle size (i.e., droplet diameter of SEDDS upon dispersion) and average droplet polydispersity index, where applicable. A manually defined descriptor denoting whether a given formulation was found to be promising in the context of its source article was also included. A formulation was considered to be promising if it was selected for further development and/or exhibited the most favourable properties (i.e., dependent on the original study) from a panel of screened formulations.
The literature-mined dataset was further extended by appending additional features relating to each component of each formulation. Drug physicochemical properties were sourced from DrugBank, while excipient properties were reported according to the literature and supplier or manufacturer information.
To obtain a tractable dataset amenable to downstream analysis and modeling, data cleaning and preprocessing were performed. First, the trade names of excipients were all converted to chemical names, to remove redundancy. For each formulation, the number of oils, surfactants, cosolvents, or other ingredients were counted and converted into a single so-called SEDDS complexity feature. This feature was a min-max normalization performed on the total number of ingredients in each formulation (x), according to:
Furthermore, features describing the oil, surfactant, and cosolvent properties of the formulation were derived from individual component properties. For instance, using the dominant fatty acid within a certain oil (or across mixtures of oils), binary features for whether there is a long aliphatic chain and/or saturated chain described the oil character of a formulation. For surfactant and cosolvent features, weight-average properties were calculated based on the proportions of each excipient in a formulation. The complete procedure and calculations used to generate the dataset are provided in the available R code.
The SEDDS dataset and related data are available in CSV formats on Open Science Framework (OSF)19. A summary of the available files is provided in Table 1. Data files contained in the Components folder report all individual drugs and excipients, as well as their associated properties, collated in the final dataset, sedds_df.csv . The data contains 20 drugs, 44 unique oils, 31 unique surfactants, and 17 unique cosolvents. In total, the final cleaned dataset comprised 29 features for 668 SEDDS formulations (Table 2).
Given the dataset is sourced from the literature, the validity is directly related to the quality of the source studies. Therefore, limitations pertaining to the sparsity and accuracy of reported data, and the influence of publication bias, are to be expected. By including a range of drugs and all their available SEDDS formulations, we strove to impart the dataset with a more representative breadth of samples (i.e., combination of BCS II and IV drugs; some drugs are less amenable to SEDDS formulations than others). Furthermore, studies were assessed for completeness of information and uniqueness of the reported formulation. This ensured all compositional details are available for each sample. All possible features from the source studies were included in the dataset, but there is scope to potentially expand it with additional descriptors, such as structural representations (e.g., for drugs or excipients) for researchers aiming to use the dataset in ML applications. It is notable that droplet size and PDI of SEDDS upon dispersion are not reported in all cases, with only 506 (75.7%) formulations reporting the former and 289 (43.3%) formulations reporting the latter. While this is related to the nature of the data, missing data may be addressed through imputation, the application of synthetic data generation techniques, or by omission.
All data cleaning and preparation was performed in R (version 4.2.1). The R code used to generate the dataset is available on OSF as a markdown notebook.
Amidon, G. L., Lennernäs, H., Shah, V. P. & Crison, J. R. A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability. Pharm. Res. 12, 413–420 (1995).
Article CAS PubMed Google Scholar
Lipinski, C. A., Lombardo, F., Dominy, B. W. & Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 46, 3–26 (2001).
Article CAS PubMed Google Scholar
Butler, J. M. & Dressman, J. B. The Developability Classification System: Application of Biopharmaceutics Concepts to Formulation Development. J. Pharm. Sci. 99, 4940–4954 (2010).
Article CAS PubMed Google Scholar
Stegemann, S. et al. Trends in oral small-molecule drug discovery and product development based on product launches before and after the Rule of Five. Drug Discov. Today 28, 103344 (2023).
Article CAS PubMed Google Scholar
Shultz, M. D. Two Decades under the Influence of the Rule of Five and the Changing Properties of Approved Oral Drugs. J. Med. Chem. 62, 1701–1714 (2019).
Article CAS PubMed Google Scholar
Pouton, C. W. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and ‘self-microemulsifying’ drug delivery systems. Eur. J. Pharm. Sci. 11, S93–S98 (2000).
Article CAS PubMed Google Scholar
Cherniakov, I., Domb, A. J. & Hoffman, A. Self-nano-emulsifying drug delivery systems: an update of the biopharmaceutical aspects. Expert Opin. Drug Deliv. 12, 1121–1133 (2015).
Article CAS PubMed Google Scholar
Savla, R., Browne, J., Plassat, V., Wasan, K. M. & Wasan, E. K. Review and analysis of FDA approved drugs using lipid-based formulations. Drug Dev. Ind. Pharm. 43, 1743–1758 (2017).
Article CAS PubMed Google Scholar
Tran, P. & Park, J.-S. Recent trends of self-emulsifying drug delivery system for enhancing the oral bioavailability of poorly water-soluble drugs. J. Pharm. Investig. 51, 439–463 (2021).
Siepmann, J. et al. Lipids and polymers in pharmaceutical technology: Lifelong companions. Int. J. Pharm. 558, 128–142 (2019).
Article CAS PubMed Google Scholar
Pouton, C. W. Formulation of self-emulsifying drug delivery systems. Adv. Drug Deliv. Rev. 25, 47–58 (1997).
Bannigan, P. et al. Machine learning models to accelerate the design of polymeric long-acting injectables. Nat. Commun. 14, 35 (2023).
Article ADS CAS PubMed PubMed Central Google Scholar
Hsueh, H. T. et al. Machine learning-driven multifunctional peptide engineering for sustained ocular drug delivery. Nat. Commun. 14, 2509 (2023).
Article ADS CAS PubMed PubMed Central Google Scholar
Xu, Y. et al. AGILE Platform: A Deep Learning-Powered Approach to Accelerate LNP Development for mRNA Delivery. Preprint at https://doi.org/10.1101/2023.06.01.543345 (2023).
Brinkmann, J., Exner, L., Luebbert, C. & Sadowski, G. In-Silico Screening of Lipid-Based Drug Delivery Systems. Pharm. Res. 37, 249 (2020).
Article CAS PubMed PubMed Central Google Scholar
Bennett-Lenane, H. et al. Artificial Neural Networks to Predict the Apparent Degree of Supersaturation in Supersaturated Lipid-Based Formulations: A Pilot Study. Pharmaceutics 13, 1398 (2021).
Article CAS PubMed PubMed Central Google Scholar
Bennett-Lenane, H. et al. Applying Computational Predictions of Biorelevant Solubility Ratio Upon Self-Emulsifying Lipid-Based Formulations Dispersion to Predict Dose. Number. J. Pharm. Sci. 110, 164–175 (2021).
Article CAS PubMed Google Scholar
Gao, H. et al. Integrated in silico formulation design of self-emulsifying drug delivery systems. Acta Pharm. Sin. B 11, 3585–3594 (2021).
Article ADS CAS PubMed PubMed Central Google Scholar
Zaslavsky, J. A dataset of formulation compositions for self-emulsifying drug delivery systems, Open Science Framework, https://doi.org/10.17605/osf.io/hvefk (2023).
This work was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant (RGPIN-2022-04910) awarded to CA, as well as an NSERC CGS M and a Toronto Cannabis and Cannabinoid Research Consortium (TC3) Fellowship awarded to JZ. This research relates to the Acceleration Consortium at the University of Toronto, which receives funding from the Canada First Research Excellence Fund (CFREF).
Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, M5S 3M2, Canada
Jonathan Zaslavsky & Christine Allen
Department of Chemical Engineering & Applied Chemistry, University of Toronto, Toronto, ON, M5S 3E5, Canada
Acceleration Consortium, Toronto, ON, M5S 3H6, Canada
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
J.Z. performed the research, processed the data, and wrote the original draft. C.A. reviewed and edited the manuscript. All authors read and approved the final version of the manuscript.
CA is a founding member of a new company, 15073383 Canada Inc.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Zaslavsky, J., Allen, C. A dataset of formulation compositions for self-emulsifying drug delivery systems. Sci Data 10, 914 (2023). https://doi.org/10.1038/s41597-023-02812-w
DOI: https://doi.org/10.1038/s41597-023-02812-w
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative
Scientific Data (Sci Data) ISSN 2052-4463 (online)
Cure Insomnia Forever Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.